Publications by authors named "Eugenia Nikonorova"
Article Synopsis
- Psoriasis is an ongoing skin condition driven by inflammation and immune responses, with recent advances in targeted therapies showing success for moderate-to-severe cases.
- A study evaluated TNFα inhibitors (etanercept, adalimumab, infliximab) over 16 weeks in psoriasis patients, finding a 63% positive treatment response but varying effectiveness among the drugs.
- Baseline levels of IL20 showed potential as a predictor of treatment success, while decreases in certain cytokines were noted in patients who responded positively to the therapy, highlighting differing immune responses among individuals.
